In this morning's London Times newspaper, there was an article on CRP and
cardiac risk based on a paper due to be published this week in the journal
CIRCULATION. Perhaps the answer as to how useful CRP would be in evaluating
cardiovascular risk, with other factors already understood, will be there
(but I doubt it). Expect a flood of new requests!
Malcolm Gray
-----Original Message-----
From: Bruce Campbell
To: [log in to unmask]
Sent: 20/1/2003 11:16 PM
Subject: Re: sensitive CRP and CHD
Sensitive CRP assays can only discriminate between those with and
without
active atherosclerosis when there are couple of hundred subjects in each
group. Sensitive CRP measurements can't confidently discriminate
between
individuals. Our calculations indicate that the number of samples
required
from an individual to obtain a clinically useful estimate of their true
hs-CRP concentration lies between 10 and 50. See our Ann Clin Biochem
paper referenced below and the other articles as well which give more
reasons why hs-CRP is not clinically useful.
Ridker has suggested that we could just do a number of measurements over
time and pick the lowest value. However there are a number of untested
assumptions inherent in this idea that would need to be validated. The
experiments required to identify and quantify the factors which
contribute
to both minor and major variation in plasma CRP concentrations are not
going to be easy to perform. We are setting up a study to follow
subjects
over time while they record a health diary to see whether clinically
significant intra-individual variations in hs-CRP are subjectively or
objectively identifiable. It is our hypothesis that many such
variations
will be silent.
Campbell B et al. Limited clinical utility of high-sensitivity plasma
C-reactive protein assays. Ann Clin Biochem 2002;39:85-88
Kushner I. C-reactive protein and atherosclerosis. Science
2002;297:520-21
Kushner I, Sehgal AR. Is high-sensitivity C-reactive protein an
effective
screening test for cardiovascular risk? Arch Int Med 2002;162:867-9
Levinson SS, Elin RJ. What is C-reactive protein telling us about
coronary
artery disease? Arch Int Med 2002;162:389-95
Bruce Campbell
****************************************
Bruce Campbell FRCPA FAACB
Sullivan Nicolaides Pathology
Ph 61 (0)7 3377 8672
Fax 61 (0)7 3870 5989
Email [log in to unmask]
****************************************
Craig Webster
<[log in to unmask]> To:
[log in to unmask]
Sent by: clinical cc:
biochemistry discussion Subject: Re:
sensitive CRP and CHD
list
<ACB-CLIN-CHEM-GEN@JISCM
AIL.AC.UK>
21/01/03 04:28
Please respond to Craig
Webster
Sensitive CRP was mentioned in a Plenary Lecture by Matt McQueen at the
ICCC
kyoto. Within individual variation data suggests that up to 5
measurements
of sensitive CRP may be neccessary to obtain a value that can be used in
the
assessment of CHD risk. WHich is probably even better news for
manufacturers!
The theory that atherlosclerosis is a chronic low grade inflammatory
reaction underpins its measurement.
I always thought that CRP was probably under requested in the past due
to
long turn around times etc. Now that we can turn the test around quickly
surely we are seeing the benefits of all our execellent work on
improving
the service we provide :-)
Craig Webster
Principal Clinical Biochemist
Nottingham City Hospital
-----Original Message-----
From: clinical biochemistry discussion list
[mailto:[log in to unmask]]On Behalf Of David Brown
Sent: 20 January 2003 17:25
To: [log in to unmask]
Subject: Re: [ACB-CLIN-CHEM-GEN] sensitive CRP and CHD
Like everything else, apparently, new "sensitive" CRP
is the same non specific CRP we have been measuring
for years, only it is more sensitive in the lower
range. There is sufficient interest in this assay as a
cardiac risk factor, that there is more than one assay
method on the market. My experience of assaying CRP's
consisted of seeing - most below measurable range -
and the rest so sky high, that I wondered if the test
was really necessary (but that was a few years ago).
Now I may be led to believe that it is as valuable as
measuring a total cholesterol. There are several major
studies indicating this. For those who are
interested,this web page explains sensitive CRP (from
a manufacturers point of view) and gives some
references too.
http://www.sonoraquest.com/documents/CardioCRP.pdf
Best wishes
David Brown
--- "Mainwaring-Burton Richard (RGZ)"
<[log in to unmask]>
wrote: > In the light of the significant numbers of
raised
> (non-sensitive) CRPs we
> report for a plethora of reasons, how do we pick out
> the significant
> elevations of sensitive CRP ?
>
> Suggested stratigies :
> 1. do a low sensitivity assay first
> 2. apologise to potential CHD patients with
> high CRP - test no good
> until arthritis/crohns/flu/etc cleared up
> 3. wait for the cardio-specific version ?
>
> With best wishes - happy new year
> Richard
> Biochemistry Department
> Queen Mary's Hospital
> Sidcup, Kent
> DA14 6LT
>
>
>
> -----Original Message-----
> From: Paul Collinson
> [mailto:[log in to unmask]]
> Sent: Tuesday, January 14, 2003 21:07
> To: [log in to unmask]
> Subject: Re: sensetive CRP
>
>
> In message <[log in to unmask]>,
> Dr Clara Henig
> <[log in to unmask]> writes
> >Dear all
> >
> >What do you know about the utilities of sensitive
> CRP as a CHD marker?
> >Does anyone use it routinely? What are your
> recommendations?
> >
> >Thanks
> >Clara
> >
> >------ACB discussion List Information--------
> >This is an open discussion list for the academic
> and clinical
> >community working in clinical biochemistry.
> >Please note, archived messages are public and can
> be viewed
> >via the internet. Views expressed are those of the
> individual and
> >they are responsible for all message content.
> >
> >ACB Web Site
> >http://www.acb.org.uk
> >List Archives
>
>http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
> >List Instructions (How to leave etc.)
> >http://www.jiscmail.ac.uk/
>
> There have been a number of publications by Paul
> Ridker
>
> We use it routinely for priomary risk stratification
> with the cut-off for
> low
> risk <1, inetremediate 1-3 and high risk >3 (mg/L)
>
> --
> Paul Collinson
>
> ------ACB discussion List Information--------
> This is an open discussion list for the academic and
> clinical
> community working in clinical biochemistry.
> Please note, archived messages are public and can be
> viewed
> via the internet. Views expressed are those of the
> individual and
> they are responsible for all message content.
>
> ACB Web Site
> http://www.acb.org.uk
> List Archives
>
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
> List Instructions (How to leave etc.)
> http://www.jiscmail.ac.uk/
>
> ------ACB discussion List Information--------
> This is an open discussion list for the academic and
> clinical
> community working in clinical biochemistry.
> Please note, archived messages are public and can be
> viewed
> via the internet. Views expressed are those of the
> individual and
> they are responsible for all message content.
>
> ACB Web Site
> http://www.acb.org.uk
> List Archives
>
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
> List Instructions (How to leave etc.)
> http://www.jiscmail.ac.uk/
__________________________________________________
Do You Yahoo!?
Everything you'll ever need on one web page
from News and Sport to Email and Music Charts
http://uk.my.yahoo.com
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
--------------------------------------------------------------------------
The information contained in this message is confidential and is intended
for the addressee only. If you have received this message in error or there
are any problems please notify the originator immediately. The unauthorised
use, disclosure, copying or alteration of this message is strictly
forbidden. This mail and any attachments have been scanned for viruses prior
to leaving Barts & The London NHS Trust network. Barts & The London NHS
Trust will not be liable for direct, special, indirect or consequential
damages arising from alteration of the contents of this message by
a third party or as a result of any virus being passed on.
--------------------------------------------------------------------------
------ACB discussion List Information--------
This is an open discussion list for the academic and clinical
community working in clinical biochemistry.
Please note, archived messages are public and can be viewed
via the internet. Views expressed are those of the individual and
they are responsible for all message content.
ACB Web Site
http://www.acb.org.uk
List Archives
http://www.jiscmail.ac.uk/lists/ACB-CLIN-CHEM-GEN.html
List Instructions (How to leave etc.)
http://www.jiscmail.ac.uk/
|